M&G

[pyad]

I mentioned this high yielding share (MNG) a while ago here. It's a FTSE100 fund manager with a short history after being demerged from Prudential so can't satisfy the five year rising div rule.

21 results out today with a final div of 12.2p, (shown as second interim, same thing) making a total for the year of 18.3p. With the shares at 200p the historical yield is 9.2%. And their stated payout policy is for a "a stable or increasing dividend". No guarantees of course.

[MDW1954]

I bought a modestly-sized chunk in January 2021, and have been very pleased so far.

MDW1954

[yorkshirelad1]

And their stated payout policy is for a "a stable or increasing dividend".

In pure MNG identity (spun out of Pru), there are only two full year dividends on record:
2020: 18.23p
2021: 18.3p (+3.83% on previous year)

[scrumpyjack]

Fairly trivial, but the sort of thing that niggles: The dividend is shown as 12.2p and the comparative dividend in the previous year is shown as 12.2p.

However the actual comparative dividend last year was not 12.2p. It was 12.23p

Seems a bit sloppy to me as a retired chartered accountant!

[monabri]

And their stated payout policy is for a "a stable or increasing dividend".

In pure MNG identity (spun out of Pru), there are only two full year dividends on record:
2020: 18.23p
2021: 18.3p (+3.83% on previous year)

+ 0.38%.

[idpickering]

I'm willing to wait a few more years so that the share has more of a history in it's own right.
The yield on offer is nice obviously, but I'm not into just chasing any old high yield.
I'm open to being proved wrong of course though. However, in the current climate who knows which share is a worthwhile bet on a hunch anyway?

Ian.

[MrFoolish]

I mentioned this high yielding share (MNG) a while ago here. It's a FTSE100 fund manager with a short history after being demerged from Prudential so can't satisfy the five year rising div rule.

21 results out today with a final div of 12.2p, (shown as second interim, same thing) making a total for the year of 18.3p. With the shares at 200p the historical yield is 9.2%. And their stated payout policy is for a "a stable or increasing dividend". No guarantees of course.

I'm not entirely sure if that makes it a HYP candidate or not in your opinion.

[pyad]

I'm not entirely sure if that makes it a HYP candidate or not in your opinion.

Put it this way, I added the share to my HYP some time ago around when it first caught my attention. I was prepared in this case to trade-off what was then a very short history against what I saw as its HYP attractions. That remains my view.

[yorkshirelad1]

2020: 18.23p
2021: 18.3p (+3.83% on previous year)

+ 0.38%.

Thank you. Pesky decimal points

[pyad]

Fairly trivial, but the sort of thing that niggles: The dividend is shown as 12.2p and the comparative dividend in the previous year is shown as 12.2p.

However the actual comparative dividend last year was not 12.2p. It was 12.23p

Seems a bit sloppy to me as a retired chartered accountant!

Yeah, well in my fairly extensive experience chartered accountants usually make poor investors, which is the opposite of what a casual observer might think was the case since we know how to read balance sheets etc. etc.

The reasons I think are an excessive caution that comes with the CA personality accompanied by the fear of even modest risk, and a concern with trivia and detail as distinct from the bigger picture. There are some well known exceptions but they are just that, exceptions.

[idpickering]

Despite my reluctance to invest in this company just yet, which I voiced further up this thread, I'm not too proud to say I've had a change of heart. A few minutes ago I dropped GSK, and bought M&G with most of the proceeds. My reasoning is that GSK has been a serial underperformer for me, despite the attractive dividend yields they've paid to me for ten years. As I guess most here know, GSK are splitting the company in two this year, and also intend lowering the dividends too. With all this in mind, I couldn't see the point in just blindly hanging onto my GSK shares.

There was enough left over after this transaction, that I topped up my Persimmon holdings too. Now, where's my tin hat?.....

Ian.